Characterization and tissue-specific expression of human LRIG2.
about
LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradationLrig2-deficient mice are protected against PDGFB-induced gliomaVertebrate Lrig3-ErbB interactions occur in vitro but are unlikely to play a role in Lrig3-dependent inner ear morphogenesis.LRIG2 expression and prognosis in non-small cell lung cancer.The LRIG family: enigmatic regulators of growth factor receptor signaling.Soluble LRIG2 ectodomain is released from glioblastoma cells and promotes the proliferation and inhibits the apoptosis of glioblastoma cells in vitro and in vivo in a similar manner to the full-length LRIG2LRIG and cancer prognosis.The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status.Expression of LRIG1 is Associated With Good Prognosis for Human Non-small Cell Lung Cancer.Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity.Mouse models for gastric cancer: Matching models to biological questions.Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer.Urofacial syndrome: a genetic and congenital disease of aberrant urinary bladder innervation.LRIG1 improves chemosensitivity through inhibition of BCL-2 and MnSOD in glioblastoma.LRIG1 is a prognostic biomarker in non-small cell lung cancer.Over-expression of LRIG3 suppresses growth and invasion of bladder cancer cells.Effect of over-expressed LRIG3 on cell cycle and survival of glioma cells.Effect of silencing LRIG3 gene on the proliferation and apoptosis of bladder cancer T24 cells.Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity.Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma.Role and mechanism of action of LRIG1 in ovarian cancer cell line and VP16 drug-resistant cell line.The negative regulation of miR-149-5p in melanoma cell survival and apoptosis by targeting LRIG2.A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity.A protein interaction network centered on leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) regulates growth factor receptors.Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression.Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma.LRIG2 is a growth suppressor of Hec-1A and Ishikawa endometrial adenocarcinoma cells by regulating PI3K/AKT- and EGFR-mediated apoptosis and cell-cycle.LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer.
P2860
Q24563349-E6212619-E237-4644-B8E2-6AED5DE0323CQ28506352-F13AB8DE-B997-4CC5-9703-DF0D38C3B97BQ33529059-27F2EAB2-684B-4870-8218-11D38817E0BCQ33844052-51AFE6C0-292C-4723-AFB2-22AF13227511Q34276176-31D29994-DD54-47B4-BE9D-FA67EC086035Q34421021-2CF3F2A2-B0ED-44AE-923C-2D6960DD8ED3Q35626430-5A3FA643-CDB7-4738-8533-6094353333BCQ37109236-329F6B80-3BEE-4FA4-BA03-6B6F15D65C66Q37328598-010203B6-48C7-4323-B734-CA0CD6A21925Q37430574-7F619408-8325-43A3-885E-EA9E4598141FQ37664258-0D1B82CA-7355-4A08-9D8B-9E703D401BC6Q37681779-2BD2C4C0-65B3-4426-846E-C78BD0A4E695Q38119849-CE883BBA-BF2B-40CF-A898-304B41C937E1Q38935017-11ACF062-091C-4D81-83E9-2C18ACAD375EQ39024741-EDBA0549-1E2B-459E-8F89-1953255699C3Q39197748-7237F00C-B988-469A-840C-5843091D057FQ39450728-DDA3C2F8-6E61-4359-AA4F-8EB4A8615295Q39555935-857F6397-191B-467B-9AB7-08DF60466199Q39574128-D44ACE3A-D6A1-4FFD-8822-4E8405D69004Q40070276-6CEE7D81-B770-4BA6-976C-63B14963E5CEQ41389592-F86731D3-B755-4C5D-BE64-DF80C431E17EQ42367926-8303595D-11FF-42DB-BC60-9BD13532A913Q42498384-7FAE9AE2-F777-4A51-9CEC-F069B6012B46Q47215868-B236B80D-5A59-4CE0-BBAC-CF796954DBD0Q48578773-57C82EF7-1E43-4A40-B17C-61CF3D8936EBQ49390262-45DF3D25-7683-4509-B5D0-12267715D434Q49864928-39FE29EF-782C-4C59-A6BA-CE521CA1CD1FQ50047531-7BF3B8EF-A392-4092-A0E5-C0F648C7D3BD
P2860
Characterization and tissue-specific expression of human LRIG2.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Characterization and tissue-specific expression of human LRIG2.
@ast
Characterization and tissue-specific expression of human LRIG2.
@en
type
label
Characterization and tissue-specific expression of human LRIG2.
@ast
Characterization and tissue-specific expression of human LRIG2.
@en
prefLabel
Characterization and tissue-specific expression of human LRIG2.
@ast
Characterization and tissue-specific expression of human LRIG2.
@en
P2093
P1433
P1476
Characterization and tissue-specific expression of human LRIG2.
@en
P2093
Anna Starefeldt
Camilla Holmlund
Dongsheng Guo
Håkan Hedman
Jonas Nilsson
Roger Henriksson
P356
10.1016/J.GENE.2004.02.002
P407
P577
2004-05-01T00:00:00Z